Pradefovir
(Synonyms:帕拉德福韦)
目录号 : KE9868
CAS No. : 625095-60-5
纯度 : ≥95%
Pradefovir is a reverse transcriptase inhibitor potentially for treatment of chronic HBV infection. Pradefovir is also a liver-targeted prodrug of adefovir. After metabolic activation, Pradefovir was converted to PMEA (9-(2-phosphonylmethoxyethyl)adenine ) in human liver microsomes with a K(m) of 60 microM, a maximum rate of metabolism of 228 pmol/min/mg protein, and an intrinsic clearance of about 359 ml/min.
Other Forms of Rapamycin:
KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
KKL 顾客使用本产品发表的 0 篇科研文献
暂无科研文献
生物活性 |
Pradefovir is a reverse transcriptase inhibitor potentially for treatment of chronic HBV infection. Pradefovir is also a liver-targeted prodrug of adefovir. After metabolic activation, Pradefovir was converted to PMEA (9-(2-phosphonylmethoxyethyl)adenine ) in human liver microsomes with a K(m) of 60 microM, a maximum rate of metabolism of 228 pmol/min/mg protein, and an intrinsic clearance of about 359 ml/min.
|
分子式 |
C17H19ClN5O4P
|
分子量 |
423.79
|
CAS号 |
625095-60-5
|
中文名称 |
帕拉德福韦
|
运输条件 |
Room temperature in continental US; may vary elsewhere.
|
储存方式 |
Store at -20˚C
|